Sanofi: A Leader In Life-Saving Vaccines And Treatments [Seeking Alpha]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Seeking Alpha
On May 20, 2024, SNY announced additional results from a Phase 3 clinical trial that demonstrated Dupixent's greater efficacy in COPD treatment relative to my expectations. Dupixent sales amounted to 2.84 billion euros in the first three months of 2024, up 22.4% year-on-year. The French pharmaceutical company has a strong balance sheet, a dividend yield of 4.21%, and has been showing steady year-on-year revenue growth. Thus, I'm initiating coverage of Sanofi with a"buy" rating. Sanofi ( NASDAQ: SNY OTCPK:SNYNF ) is one of the largest pharmaceutical companies in Europe, with a leading position in the global anti-inflammatory therapeutics market. Investment thesis Wall Street's indifference to France's largest pharmaceutical company is reflected in its share price continuing Recommended For You Recommended For You About SNY Stock
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments [Yahoo! Finance]Yahoo! Finance
- Sanofi and Biovac partner to produce polio vaccines in Africa [Yahoo! Finance]Yahoo! Finance
- Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive CommitteeGlobeNewswire
- Euronext Paris Showcases Three Prominent Dividend Stocks [Yahoo! Finance]Yahoo! Finance
- Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 6/11/24 - Form 6-K
- 5/30/24 - Form 6-K
- 5/28/24 - Form 6-K
- SNY's page on the SEC website